arrow_back Back to App

Increased Price Transparency for Lab Tests in Medicare

This act aims to increase price transparency for laboratory tests for individuals using the Medicare program. Starting in 2025, healthcare providers will be required to publicly disclose test prices, allowing patients to better understand costs and make informed decisions about their healthcare. This is intended to facilitate price comparison and potentially reduce diagnostic expenses.
Key points
Laboratory test providers must publish test prices on their websites starting January 1, 2025.
Price information will include discounted cash prices, and deidentified minimum and maximum negotiated rates with insurers.
Prices must include all ancillary services related to the test, such as specimen collection.
Non-compliance with the regulations may result in financial penalties.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_3248
Sponsor: Rep. Miller-Meeks, Mariannette [R-IA-1]
Process start date: 2023-05-11
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Diagnostic Lab Testing Transparency Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_3248.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-05-11.

What are the main provisions?

Key points include:

  • Laboratory test providers must publish test prices on their websites starting January 1, 2025.
  • Price information will include discounted cash prices, and deidentified minimum and maximum negotiated rates with insurers.
  • Prices must include all ancillary services related to the test, such as specimen collection.
  • Non-compliance with the regulations may result in financial penalties.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Miller-Meeks, Mariannette [R-IA-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health